Gene · 3108
Papers2,126
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,126
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms. | Vaccines (Basel) | 2023 | 36851285 | PubTator, text mining | PubMed |
| TREM2 as a Prognostic Biomarker for Osteosarcoma Microenvironment Remodeling. | J Oncol | 2023 | 36844870 | PubTator, text mining | PubMed |
| Monocytic HLA-DR Expression in Immune Responses of Acute Pancreatitis and COVID-19. | Int J Mol Sci | 2023 | 36834656 | PubTator, text mining | PubMed |
| Citrullination modulates antigen processing and presentation by revealing cryptic epitopes in rheumatoid arthritis. | Nat Commun | 2023 | 36828807 | PubTator, text mining | PubMed |
| Transcriptomic analysis of pancreatic adenocarcinoma specimens obtained from Black and White patients. | PLoS One | 2023 | 36812168 | PubTator, text mining | PubMed |
| MS4A4A modifies the risk of Alzheimer disease by regulating lipid metabolism and immune response in a unique microglia state. | medRxiv | 2023 | 36798226 | PubTator, text mining | PubMed |
| A new immune signature for survival prediction and immune checkpoint molecules in non-small cell lung cancer. | Front Oncol | 2023 | 36793597 | PubTator, text mining | PubMed |
| Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma. | Cancer Epidemiol Biomarkers Prev | 2023 | 36790339 | PubTator, text mining | PubMed |
| Identification of tumor antigens and immune subtypes of acute myeloid leukemia for mRNA vaccine development. | Clin Transl Oncol | 2023 | 36781600 | PubTator, text mining | PubMed |
| Identification of platinum resistance-related gene signature for prognosis and immune analysis in bladder cancer. | Front Genet | 2023 | 36777726 | PubTator, text mining | PubMed |
| Correlation analysis between immune-related genes and cell infiltration revealed prostate cancer immunotherapy biomarkers linked to T cells gamma delta. | Sci Rep | 2023 | 36774376 | PubTator, text mining | PubMed |
| HGCA2.0: An RNA-Seq Based Webtool for Gene Coexpression Analysis in Homo sapiens. | Cells | 2023 | 36766730 | PubTator, text mining | PubMed |
| Integrated analysis of RNA methylation regulators crosstalk and immune infiltration for predictive and personalized therapy of diabetic nephropathy. | Hum Genomics | 2023 | 36765416 | PubTator, text mining | PubMed |
| Data on the transcriptional response to MESH1 knockdown and mammalian stringent response. | Data Brief | 2023 | 36761407 | PubTator, text mining | PubMed |
| The mode of action of tapasin on major histocompatibility class I (MHC-I) molecules. | J Biol Chem | 2023 | 36758805 | PubTator, text mining | PubMed |
| Exploring the shared molecular mechanism of microvascular and macrovascular complications in diabetes: Seeking the hub of circulatory system injury. | Front Endocrinol (Lausanne) | 2023 | 36755923 | PubTator, text mining | PubMed |
| Multimodal single-cell analyses of peripheral blood mononuclear cells of COVID-19 patients in Japan. | Sci Rep | 2023 | 36732528 | PubTator, text mining | PubMed |
| Proteogenomics of diffuse gliomas reveal molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms. | Nat Commun | 2023 | 36720864 | PubTator, text mining | PubMed |
| Scarcity nationalism during COVID-19: Identifying the impact on trade costs. | Econ Lett | 2023 | 36714269 | PubTator, text mining | PubMed |
| The relevance of HLA class II genes in JAK2 V617F-positive myeloproliferative neoplasms. | Hum Immunol | 2023 | 36707384 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3108/papers?page=13